Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live...
Vous n'êtes pas connecté
Blocking brain damage triggered by a glioblastoma, an aggressive brain cancer, may slow the growth of the cancer and allow the brain to keep working better for longer, according to a new study led by UCL (University College London) researchers.
Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live...
The anti-obesity drug tirzepatide, known as Mounjaro (for diabetes) and Zepbound (for obesity), has been found to reduce breast cancer growth linked...
A new study sheds light on how our brains rhythmically organize memories at the level of individual nerve cells. Researchers in Germany have found...
A new study sheds light on how our brains rhythmically organize memories at the level of individual nerve cells. Researchers in Germany have found...
In a new study led by the University of Pennsylvania School of Veterinary Medicine (Penn Vet) and Children's Hospital of Philadelphia (CHOP),...
A groundbreaking Boston University study has uncovered why breast cancer in people with type 2 diabetes is often more aggressive and harder to treat....
A groundbreaking Boston University study has uncovered why breast cancer in people with type 2 diabetes is often more aggressive and harder to treat....
A new research paper was published in Volume 16 of Oncotarget on July 25, 2025, titled “Dissecting the functional differences and clinical...
A new study led by researchers from the University of Pittsburgh School of Medicine and UPMC has found that exposure to long-wavelength red light may...
Glioblastoma multiforme (GBM) is the most aggressive and common type of brain tumour, affecting nearly 250,000 people worldwide every year. Despite...